APO Research
Talk to an analyst

APO RESEARCH · REPORT

Continuous Glucose Monitor (CGM) Solution

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Continuous Glucose Monitor (CGM) Solution Market Analysis and Forecast 2026-2032

16 April 2026258 pages

Choose your research edition.

Industry ResearchContinuous Glucose Monitor (CGM) Solution Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Continuous Glucose Monitor (CGM) Solution Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Continuous Glucose Monitor (CGM) Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Continuous Glucose Monitor (CGM) Solution Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Continuous Glucose Monitor (CGM) Solution Market Analysis and Forecast 2026-2032258 pages · $4,950 USD

Market perspective

The global Continuous Glucose Monitor (CGM) Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Continuous Glucose Monitor (CGM) Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Continuous Glucose Monitor (CGM) Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Continuous Glucose Monitor (CGM) Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Continuous Glucose Monitor (CGM) Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Continuous Glucose Monitor (CGM) Solution include Roche, Nutrisense, Levels Health, Eversense, Abbott, Dexcom, Medtronic, Changsha Sinocare and Beijing Yicheng Bioelectronics Technology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Continuous Glucose Monitor (CGM) Solution, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Continuous Glucose Monitor (CGM) Solution, also provides the revenue of main regions and countries. Of the upcoming market potential for Continuous Glucose Monitor (CGM) Solution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Continuous Glucose Monitor (CGM) Solution revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Continuous Glucose Monitor (CGM) Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Continuous Glucose Monitor (CGM) Solution revenue, projected growth trends, production technology, application and end-user industry.

Continuous Glucose Monitor (CGM) Solution Segment by Company

Roche

Nutrisense

Levels Health

Eversense

Abbott

Dexcom

Medtronic

Changsha Sinocare

Beijing Yicheng Bioelectronics Technology

Ottai Technology (Wuxi)

Hangzhou MicroTech Medical

Continuous Glucose Monitor (CGM) Solution Segment by Type

Hardware

Software

Continuous Glucose Monitor (CGM) Solution Segment by Application

Clinical Treatment

Sports & Fitness

Others

Continuous Glucose Monitor (CGM) Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Continuous Glucose Monitor (CGM) Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Continuous Glucose Monitor (CGM) Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Continuous Glucose Monitor (CGM) Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Continuous Glucose Monitor (CGM) Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Continuous Glucose Monitor (CGM) Solution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Continuous Glucose Monitor (CGM) Solution revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hardware Major Player Table 3. Software Major Player Table 4. Global Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinical Treatment Major Player Table 6. Sports & Fitness Major Player Table 7. Others Major Player Table 8. Continuous Glucose Monitor (CGM) Solution Industry Trends Table 9. Continuous Glucose Monitor (CGM) Solution Industry Drivers Table 10. Continuous Glucose Monitor (CGM) Solution Industry Opportunities and Challenges Table 11. Continuous Glucose Monitor (CGM) Solution Industry Restraints Table 12. Global Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Continuous Glucose Monitor (CGM) Solution Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Continuous Glucose Monitor (CGM) Solution Market Share by Region (2021-2026) Table 15. Global Continuous Glucose Monitor (CGM) Solution Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Continuous Glucose Monitor (CGM) Solution Market Share by Region (2027-2032) Table 17. Global Continuous Glucose Monitor (CGM) Solution Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Players (2021-2026) Table 19. Global Continuous Glucose Monitor (CGM) Solution Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Continuous Glucose Monitor (CGM) Solution Key Players Headquarters & Area Served Table 21. Global Continuous Glucose Monitor (CGM) Solution Players, Product Type & Application Table 22. Global Continuous Glucose Monitor (CGM) Solution Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Continuous Glucose Monitor (CGM) Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Continuous Glucose Monitor (CGM) Solution Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Type (2021-2026) Table 29. Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Type (2027-2032) Table 30. Global Continuous Glucose Monitor (CGM) Solution Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Application (2021-2026) Table 34. Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Application (2027-2032) Table 35. Roche Company Information Table 36. Roche Business Overview Table 37. Roche Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Roche Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 39. Roche Recent Development Table 40. Nutrisense Company Information Table 41. Nutrisense Business Overview Table 42. Nutrisense Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Nutrisense Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 44. Nutrisense Recent Development Table 45. Levels Health Company Information Table 46. Levels Health Business Overview Table 47. Levels Health Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Levels Health Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 49. Levels Health Recent Development Table 50. Eversense Company Information Table 51. Eversense Business Overview Table 52. Eversense Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Eversense Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 54. Eversense Recent Development Table 55. Abbott Company Information Table 56. Abbott Business Overview Table 57. Abbott Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Abbott Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 59. Abbott Recent Development Table 60. Dexcom Company Information Table 61. Dexcom Business Overview Table 62. Dexcom Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Dexcom Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 64. Dexcom Recent Development Table 65. Medtronic Company Information Table 66. Medtronic Business Overview Table 67. Medtronic Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Medtronic Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 69. Medtronic Recent Development Table 70. Changsha Sinocare Company Information Table 71. Changsha Sinocare Business Overview Table 72. Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 74. Changsha Sinocare Recent Development Table 75. Beijing Yicheng Bioelectronics Technology Company Information Table 76. Beijing Yicheng Bioelectronics Technology Business Overview Table 77. Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 79. Beijing Yicheng Bioelectronics Technology Recent Development Table 80. Ottai Technology (Wuxi) Company Information Table 81. Ottai Technology (Wuxi) Business Overview Table 82. Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 84. Ottai Technology (Wuxi) Recent Development Table 85. Hangzhou MicroTech Medical Company Information Table 86. Hangzhou MicroTech Medical Business Overview Table 87. Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 89. Hangzhou MicroTech Medical Recent Development Table 90. North America Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Continuous Glucose Monitor (CGM) Solution Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe Continuous Glucose Monitor (CGM) Solution Revenue by Country (US$ Million) & (2027-2032) Table 104. China Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026) & (US$ Million) Table 105. China Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032) & (US$ Million) Table 106. China Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026) & (US$ Million) Table 107. China Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Continuous Glucose Monitor (CGM) Solution Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Continuous Glucose Monitor (CGM) Solution Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia Continuous Glucose Monitor (CGM) Solution Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Continuous Glucose Monitor (CGM) Solution Image Figure 2. Global Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Continuous Glucose Monitor (CGM) Solution Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hardware Image Figure 5. Software Image Figure 6. Global Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Continuous Glucose Monitor (CGM) Solution Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinical Treatment Image Figure 9. Sports & Fitness Image Figure 10. Others Image Figure 11. Global Continuous Glucose Monitor (CGM) Solution Market Size (US$ Million) & (2021-2032) Figure 12. Global Continuous Glucose Monitor (CGM) Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Continuous Glucose Monitor (CGM) Solution Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Continuous Glucose Monitor (CGM) Solution Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Type (2021-2032) Figure 19. Global Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Application (2021-2032) Figure 22. North America Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Continuous Glucose Monitor (CGM) Solution Revenue Share by Type (2021-2032) Figure 24. North America Continuous Glucose Monitor (CGM) Solution Revenue Share by Application (2021-2032) Figure 25. North America Continuous Glucose Monitor (CGM) Solution Revenue Share by Country (2021-2032) Figure 26. United States Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Continuous Glucose Monitor (CGM) Solution Revenue Share by Type (2021-2032) Figure 31. Europe Continuous Glucose Monitor (CGM) Solution Revenue Share by Application (2021-2032) Figure 32. Europe Continuous Glucose Monitor (CGM) Solution Revenue Share by Country (2021-2032) Figure 33. Germany Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Continuous Glucose Monitor (CGM) Solution Revenue Share by Type (2021-2032) Figure 43. China Continuous Glucose Monitor (CGM) Solution Revenue Share by Application (2021-2032) Figure 44. Asia Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Continuous Glucose Monitor (CGM) Solution Revenue Share by Type (2021-2032) Figure 46. Asia Continuous Glucose Monitor (CGM) Solution Revenue Share by Application (2021-2032) Figure 47. Asia Continuous Glucose Monitor (CGM) Solution Revenue Share by Region (2021-2032) Figure 48. Japan Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue Share by Type (2021-2032) Figure 56. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue Share by Application (2021-2032) Figure 57. SAMEA Continuous Glucose Monitor (CGM) Solution Revenue Share by Country (2021-2032) Figure 58. Brazil Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Continuous Glucose Monitor (CGM) Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software
Applications
  • Clinical Treatment
  • Sports & Fitness
  • Others
Companies covered
  • Roche
  • Nutrisense
  • Levels Health
  • Eversense
  • Abbott
  • Dexcom
  • Medtronic
  • Changsha Sinocare
  • Beijing Yicheng Bioelectronics Technology
  • Ottai Technology (Wuxi)
  • Hangzhou MicroTech Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Continuous Glucose Monitor (CGM) Solution Market by Type
  3. 1.2.1 Global Continuous Glucose Monitor (CGM) Solution Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hardware
  5. 1.2.3 Software
  6. 1.3 Continuous Glucose Monitor (CGM) Solution Market by Application
  7. 1.3.1 Global Continuous Glucose Monitor (CGM) Solution Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinical Treatment
  9. 1.3.3 Sports & Fitness
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Continuous Glucose Monitor (CGM) Solution Market Dynamics
  1. 2.1 Continuous Glucose Monitor (CGM) Solution Industry Trends
  2. 2.2 Continuous Glucose Monitor (CGM) Solution Industry Drivers
  3. 2.3 Continuous Glucose Monitor (CGM) Solution Industry Opportunities and Challenges
  4. 2.4 Continuous Glucose Monitor (CGM) Solution Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Continuous Glucose Monitor (CGM) Solution Market Perspective (2021-2032)
  2. 3.2 Global Continuous Glucose Monitor (CGM) Solution Growth Trends by Region
  3. 3.2.1 Global Continuous Glucose Monitor (CGM) Solution Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Continuous Glucose Monitor (CGM) Solution Market Size by Region (2021-2026)
  5. 3.2.3 Global Continuous Glucose Monitor (CGM) Solution Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Continuous Glucose Monitor (CGM) Solution Revenue by Players
  2. 4.1.1 Global Continuous Glucose Monitor (CGM) Solution Revenue by Players (2021-2026)
  3. 4.1.2 Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Continuous Glucose Monitor (CGM) Solution Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Continuous Glucose Monitor (CGM) Solution Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Continuous Glucose Monitor (CGM) Solution Key Players Headquarters & Area Served
  7. 4.4 Global Continuous Glucose Monitor (CGM) Solution Players, Product Type & Application
  8. 4.5 Global Continuous Glucose Monitor (CGM) Solution Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Continuous Glucose Monitor (CGM) Solution Market CR5 and HHI
  11. 4.6.3 2025 Continuous Glucose Monitor (CGM) Solution Tier 1, Tier 2, and Tier 3
5 Continuous Glucose Monitor (CGM) Solution Market Size by Type
  1. 5.1 Global Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2032)
  3. 5.3 Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Type (2021-2032)
6 Continuous Glucose Monitor (CGM) Solution Market Size by Application
  1. 6.1 Global Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2032)
  3. 6.3 Global Continuous Glucose Monitor (CGM) Solution Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Roche Continuous Glucose Monitor (CGM) Solution Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Nutrisense
  8. 7.2.1 Nutrisense Company Information
  9. 7.2.2 Nutrisense Business Overview
  10. 7.2.3 Nutrisense Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Nutrisense Continuous Glucose Monitor (CGM) Solution Product Portfolio
  12. 7.2.5 Nutrisense Recent Developments
  13. 7.3 Levels Health
  14. 7.3.1 Levels Health Company Information
  15. 7.3.2 Levels Health Business Overview
  16. 7.3.3 Levels Health Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Levels Health Continuous Glucose Monitor (CGM) Solution Product Portfolio
  18. 7.3.5 Levels Health Recent Developments
  19. 7.4 Eversense
  20. 7.4.1 Eversense Company Information
  21. 7.4.2 Eversense Business Overview
  22. 7.4.3 Eversense Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Eversense Continuous Glucose Monitor (CGM) Solution Product Portfolio
  24. 7.4.5 Eversense Recent Developments
  25. 7.5 Abbott
  26. 7.5.1 Abbott Company Information
  27. 7.5.2 Abbott Business Overview
  28. 7.5.3 Abbott Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Abbott Continuous Glucose Monitor (CGM) Solution Product Portfolio
  30. 7.5.5 Abbott Recent Developments
  31. 7.6 Dexcom
  32. 7.6.1 Dexcom Company Information
  33. 7.6.2 Dexcom Business Overview
  34. 7.6.3 Dexcom Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Dexcom Continuous Glucose Monitor (CGM) Solution Product Portfolio
  36. 7.6.5 Dexcom Recent Developments
  37. 7.7 Medtronic
  38. 7.7.1 Medtronic Company Information
  39. 7.7.2 Medtronic Business Overview
  40. 7.7.3 Medtronic Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Medtronic Continuous Glucose Monitor (CGM) Solution Product Portfolio
  42. 7.7.5 Medtronic Recent Developments
  43. 7.8 Changsha Sinocare
  44. 7.8.1 Changsha Sinocare Company Information
  45. 7.8.2 Changsha Sinocare Business Overview
  46. 7.8.3 Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Product Portfolio
  48. 7.8.5 Changsha Sinocare Recent Developments
  49. 7.9 Beijing Yicheng Bioelectronics Technology
  50. 7.9.1 Beijing Yicheng Bioelectronics Technology Company Information
  51. 7.9.2 Beijing Yicheng Bioelectronics Technology Business Overview
  52. 7.9.3 Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Product Portfolio
  54. 7.9.5 Beijing Yicheng Bioelectronics Technology Recent Developments
  55. 7.10 Ottai Technology (Wuxi)
  56. 7.10.1 Ottai Technology (Wuxi) Company Information
  57. 7.10.2 Ottai Technology (Wuxi) Business Overview
  58. 7.10.3 Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Product Portfolio
  60. 7.10.5 Ottai Technology (Wuxi) Recent Developments
  61. 7.11 Hangzhou MicroTech Medical
  62. 7.11.1 Hangzhou MicroTech Medical Company Information
  63. 7.11.2 Hangzhou MicroTech Medical Business Overview
  64. 7.11.3 Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Product Portfolio
  66. 7.11.5 Hangzhou MicroTech Medical Recent Developments
8 North America
  1. 8.1 North America Continuous Glucose Monitor (CGM) Solution Revenue (2021-2032)
  2. 8.2 North America Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2032)
  3. 8.2.1 North America Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026)
  4. 8.2.2 North America Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032)
  5. 8.3 North America Continuous Glucose Monitor (CGM) Solution Revenue Share by Type (2021-2032)
  6. 8.4 North America Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2032)
  7. 8.4.1 North America Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026)
  8. 8.4.2 North America Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032)
  9. 8.5 North America Continuous Glucose Monitor (CGM) Solution Revenue Share by Application (2021-2032)
  10. 8.6 North America Continuous Glucose Monitor (CGM) Solution Revenue by Country
  11. 8.6.1 North America Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021-2026)
  13. 8.6.3 North America Continuous Glucose Monitor (CGM) Solution Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Continuous Glucose Monitor (CGM) Solution Revenue (2021-2032)
  2. 9.2 Europe Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2032)
  3. 9.2.1 Europe Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026)
  4. 9.2.2 Europe Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032)
  5. 9.3 Europe Continuous Glucose Monitor (CGM) Solution Revenue Share by Type (2021-2032)
  6. 9.4 Europe Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2032)
  7. 9.4.1 Europe Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026)
  8. 9.4.2 Europe Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032)
  9. 9.5 Europe Continuous Glucose Monitor (CGM) Solution Revenue Share by Application (2021-2032)
  10. 9.6 Europe Continuous Glucose Monitor (CGM) Solution Revenue by Country
  11. 9.6.1 Europe Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021-2026)
  13. 9.6.3 Europe Continuous Glucose Monitor (CGM) Solution Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Continuous Glucose Monitor (CGM) Solution Revenue (2021-2032)
  2. 10.2 China Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2032)
  3. 10.2.1 China Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026)
  4. 10.2.2 China Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032)
  5. 10.3 China Continuous Glucose Monitor (CGM) Solution Revenue Share by Type (2021-2032)
  6. 10.4 China Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2032)
  7. 10.4.1 China Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026)
  8. 10.4.2 China Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032)
  9. 10.5 China Continuous Glucose Monitor (CGM) Solution Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Continuous Glucose Monitor (CGM) Solution Revenue (2021-2032)
  2. 11.2 Asia Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2032)
  3. 11.2.1 Asia Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026)
  4. 11.2.2 Asia Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032)
  5. 11.3 Asia Continuous Glucose Monitor (CGM) Solution Revenue Share by Type (2021-2032)
  6. 11.4 Asia Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2032)
  7. 11.4.1 Asia Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026)
  8. 11.4.2 Asia Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032)
  9. 11.5 Asia Continuous Glucose Monitor (CGM) Solution Revenue Share by Application (2021-2032)
  10. 11.6 Asia Continuous Glucose Monitor (CGM) Solution Revenue by Country
  11. 11.6.1 Asia Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021-2026)
  13. 11.6.3 Asia Continuous Glucose Monitor (CGM) Solution Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue (2021-2032)
  2. 12.2 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Type (2027-2032)
  5. 12.3 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Application (2027-2032)
  9. 12.5 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Country
  11. 12.6.1 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Continuous Glucose Monitor (CGM) Solution Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst